---
Free space for your campaign:
Order

Welcome to licensed pharmacies in Poland:

Non-prescription medicines delivery across Europe.

Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.

Alex (Anonymous, 83.24.68.) Warszawa 21 days ago

Whether to continue using Bisoratioif I have a preliminary diagnosis of Psoriatic arthritis?

I started taking bisoratio a little over a month ago (replacement for nibilet) I began to have pain in the joints, I was at the orthopedist, the ultrasound showed an inflammatory process, suspicion of rheumatism, and yesterday the doctor made a preliminary diagnosis of psoriatic arthritis! Now a question about taking bisoratio! To continue and whether not! After all, the doctors did not say anything, and I only saw psoriasis in the contraindications

1 answer

* required field

You can drag the photo file here.

* required field

Notify of a new answer.
Other messages will not be sent.

Suggested Products

Space for your product

Your product would fit here?
Your product would fit here?

Set up a sponsored products campaign yourself:

Check
Katarzyna Chadryś

Katarzyna Chadryś Pharmacist, Editor

20 days ago

Bisoratio is a prescription drug, the continuation or discontinuation of its use should be decided by a doctor. Do not stop taking the drug on your own. In this case, you should discuss the safety of continuing therapy with your doctor, who is familiar with your test results, symptoms and other medications used.

If necessary, you can arrange a teleconsultation here, it takes place in Polish:

https://www.gdziepolek.pl/telekonsultacja

Here you can check the availability of the drug in pharmacies and make a reservation:

https://www.gdziepolek.pl/produkty/12171/bisoratio-5-tabletki/apteki

Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.

Specialists